Advances of MR imaging in glioma: what the neurosurgeon needs to know
-
By
-
Anna Falk Delgado
-
June 21, 2025
-
0 min
Clinical Report: Advances in MRI Techniques for Glioma Management
Overview
High-grade gliomas remain aggressive brain tumors with poor prognosis despite multimodal treatment. Advanced MRI techniques, including perfusion imaging and diffusion-weighted imaging, provide critical insights into tumor biology, aiding diagnosis, surgical planning, and treatment monitoring.
Background
High-grade gliomas (HGGs) are among the most lethal primary brain tumors, characterized by infiltrative growth and molecular heterogeneity. The 2021 WHO classification integrates molecular diagnostics with histology, refining tumor subtypes and impacting prognosis and treatment. MRI is central to glioma care, offering superior soft tissue contrast and advanced physiological imaging methods. Techniques such as perfusion MRI and diffusion-weighted imaging enhance understanding of tumor vascularity and microstructure, informing clinical decisions.
Data Highlights
| Perfusion MRI Technique | Contrast Agent | Key Parameters | Advantages | Limitations |
|---|---|---|---|---|
| Dynamic Susceptibility Contrast (DSC) | Gadolinium-based | CBV, CBF, MTT, TTP | High SNR, rapid acquisition, widely validated | Susceptible to artifacts near air-bone interfaces, affected by hemorrhage/calcification |
| Dynamic Contrast-Enhanced (DCE) | Gadolinium-based | Vp, Ktrans, Ve | Less sensitive to susceptibility artifacts, useful in hemorrhagic/calcified lesions | Lower SNR, complex post-processing, variable protocols |
| Arterial Spin Labelling (ASL) | None (endogenous tracer) | CBF (and possible CBV) | Non-invasive, no contrast needed, useful in renal impairment and pediatrics | Lower spatial resolution, sensitive to motion/artifacts, may underestimate slow flow |
Key Findings
- High-grade gliomas are molecularly heterogeneous, requiring integrated imaging and molecular diagnostics for accurate classification.
- Perfusion MRI techniques (DSC, DCE, ASL) provide complementary information on tumor vascular physiology and malignancy.
- DSC MRI is the most commonly used perfusion method but is limited by susceptibility artifacts and hemorrhagic or calcified lesions.
- DCE MRI offers additional parameters related to vascular permeability and plasma volume, useful when DSC is limited, though it requires complex processing.
- ASL is a valuable non-contrast alternative, especially in patients contraindicated for gadolinium, but has lower resolution and sensitivity to motion.
- Diffusion-weighted imaging and diffusion tensor imaging contribute to understanding tumor cellularity and white matter tract integrity, aiding surgical planning.
Clinical Implications
Selection of MRI perfusion technique should be individualized based on patient factors, lesion characteristics, and clinical questions. Combining DSC and DCE can overcome individual limitations, while ASL offers a safe alternative in patients where contrast is contraindicated. Incorporation of diffusion imaging enhances surgical planning by delineating tumor infiltration and white matter tracts.
Conclusion
Advanced MRI techniques significantly enhance the characterization and management of gliomas by providing detailed physiological and molecular insights. Their integration into clinical practice supports improved diagnostic accuracy, treatment planning, and monitoring, ultimately aiming to improve patient outcomes.
References
- WHO Classification of CNS Tumors 2021 -- Integrated Molecular Diagnostics
- Dynamic Susceptibility Contrast MRI in Brain Tumors -- Clinical Applications
- Arterial Spin Labelling MRI -- Non-contrast Perfusion Imaging
- Diffusion Tensor Imaging and Fiber Tractography -- Surgical Planning
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.